UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

High lipoprotein(a) and high risk of mortality

European heart journal, 2019-09, Vol.40 (33), p.2760-2770

2019

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

Arteriosclerosis, thrombosis, and vascular biology, 2022-01, Vol.42 (1), p.e48

2022

Link zum Volltext

Verfügbarkeit prüfen

High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

The lancet. Diabetes & endocrinology, 2016-07, Vol.4 (7), p.577-587

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

JAMA : the journal of the American Medical Association, 2009-06, Vol.301 (22), p.2331

2009

Link zum Volltext

Verfügbarkeit prüfen

Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population

Journal of the American College of Cardiology, 2014-02, Vol.63 (5), p.470-477

2014

Link zum Volltext

Verfügbarkeit prüfen

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033

2018

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) and Cardiovascular Disease

Clinical chemistry (Baltimore, Md.), 2021-01, Vol.67 (1), p.154-166

Kamstrup, Pia R

2021

Link zum Volltext

Verfügbarkeit prüfen

Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study

Journal of the American College of Cardiology, 2020-06, Vol.75 (22), p.2873-2875

2020

Link zum Volltext

Verfügbarkeit prüfen

Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Journal of the American College of Cardiology, 2013-03, Vol.61 (11), p.1146-1156

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories

Journal of clinical microbiology, 2021-04, Vol.59 (5)

2021

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease1

Journal of lipid research, 2017-09, Vol.58 (9), p.1731-1732

Kamstrup, Pia R.

2017

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease

Journal of the American College of Cardiology, 2022-02, Vol.79 (6), p.545-558

2022

Link zum Volltext

Verfügbarkeit prüfen

Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population

JACC. Heart failure, 2016, Vol.4 (1), p.78-87

2016

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study

The lancet. Diabetes & endocrinology, 2013-11, Vol.1 (3), p.220-227

2013

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) and risk of type 2 diabetes

Clinical chemistry (Baltimore, Md.), 2010-08, Vol.56 (8), p.1252-1260

2010

Link zum Volltext

Verfügbarkeit prüfen

Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report

Arteriosclerosis, thrombosis, and vascular biology, 2016-12, Vol.36 (12), p.2421

2016

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) and familial hypercholesterolemia: Partners in crime in heritable hyperlipidemia

Atherosclerosis, 2023-01, Vol.365, p.25-26

Kamstrup, Pia R.

2023

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism

PloS one, 2016-02, Vol.11 (2), p.e0149427-e0149427

2016

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective

Atherosclerosis, 2022-05, Vol.349, p.7-16

2022

Link zum Volltext

Verfügbarkeit prüfen

Elevated Lipoprotein(a) and Risk of Ischemic Stroke

Journal of the American College of Cardiology, 2019-07, Vol.74 (1), p.54-66

2019

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study

Arteriosclerosis, thrombosis, and vascular biology, 2020-01, Vol.40 (1), p.255

2020

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) and ischemic heart disease—A causal association? A review

Atherosclerosis, 2010-07, Vol.211 (1), p.15-23

Kamstrup, Pia R

2010

Link zum Volltext

Verfügbarkeit prüfen

Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study

European heart journal, 2021-03, Vol.42 (12), p.1147-1156

2021

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease

Journal of lipid research, 2017-09, Vol.58 (9), p.1731-1732

Kamstrup, Pia R

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(80)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High lipoprotein(a) and high risk of mortality

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

Lipoprotein(a) and Cardiovascular Disease

Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study

Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories

Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease1

Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease

Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population

Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study

Lipoprotein(a) and risk of type 2 diabetes

Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report

Lipoprotein(a) and familial hypercholesterolemia: Partners in crime in heritable hyperlipidemia

Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism

Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective

Elevated Lipoprotein(a) and Risk of Ischemic Stroke

Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study

Lipoprotein(a) and ischemic heart disease—A causal association? A review

Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study

Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease

Suchergebnisse filtern